Your browser doesn't support javascript.
loading
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated Individuals.
Gallagher, Kathleen M E; Leick, Mark B; Larson, Rebecca C; Berger, Trisha R; Katsis, Katelin; Yam, Jennifer Y; Maus, Marcela V.
Afiliación
  • Gallagher KME; Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Larson RC; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USAand.
  • Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Katsis K; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Yam JY; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Maus MV; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Clin Infect Dis ; 75(1): e869-e873, 2022 08 24.
Article en En | MEDLINE | ID: mdl-35278306
ABSTRACT
COVID-19 breakthrough cases among vaccinated individuals demonstrate the value of measuring long-term immunity to SARS-CoV-2 and its variants. We demonstrate that anti-spike T-cell responses and IgG antibody levels are maintained but decrease over time and are lower in BNT162b2- versus mRNA-1273-vaccinated individuals. T-cell responses to the variants are relatively unaffected.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos